Sung-Hwan Cho
Directeur Général chez CHOA PHARMACEUTICAL CO., LTD.
Fortune : 2 M $ au 30/04/2024
Profil
Sung-Hwan Cho is currently the Vice Chairman & Co-Chief Executive Officer at ChoA Pharmaceutical Co., Ltd.
and the President & Chief Executive Officer at Medipharm.
He has an undergraduate degree from Korea University and a graduate degree from Chung-Ang University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2023 | 1 849 162 ( 5,97% ) | 2 M $ | 30/04/2024 |
Postes actifs de Sung-Hwan Cho
| Sociétés | Poste | Début |
|---|---|---|
| CHOA PHARMACEUTICAL CO., LTD. | Directeur Général | - |
Medipharm
 Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Directeur Général | - |
Formation de Sung-Hwan Cho
| Korea University | Undergraduate Degree |
| Chung-Ang University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CHOA PHARMACEUTICAL CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Medipharm
Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Distribution Services |